Inactive Instrument

News Phase Holographic Imaging PHI AB Swiss Exchange

Equities

SE0005504636

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

Mar. 27	Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI
Mar. 14	Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PHI announces conference schedule for spring 2024	Apr. 02	AQ
Interim Report 3 2023/24	Mar. 27	AQ
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 27	CI
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)	Mar. 14	AQ
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	Mar. 14	CI
Shaping the future of Regenerative Medicine - PHI's vision for QPI in Cell Therapy Manufacturing	Mar. 11	AQ
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	Mar. 11	CI
New Distributor Partner Manager at Altium set to enhance global sales for PHI	Mar. 05	AQ
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB	Feb. 26	AQ
PHI to BioStock: "We aim to revolutionize the regenerative medicine market "	Feb. 21	AQ
PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024	Feb. 07	AQ
PHI announces extraordinary quarter sales of about 5MSEK - marks the highest ever in Company history	Jan. 30	AQ
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	Jan. 30	CI
Interim Report 2 2023/24	Dec. 21	AQ
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 21	CI
PHI appoints Pareto Securities AB to act as a liquidity provider for the Company's share	Dec. 15	AQ
PHI granted patent on synthetic antibodies in the EU	Dec. 07	AQ
Directed issue registered at the Companies Registration Office	Nov. 23	AQ
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)	Nov. 15	AQ
BioStock: PHI's CEO reflects on the Company's momentum	Nov. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Phase Holographic Imaging PHI AB Swiss Exchange

Equities

SE0005504636

Summary

Filters